STOCK TITAN

Algorhythm Holdings (NASDAQ: RIME) may issue 5,000,000 shares to settle claim

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Algorhythm Holdings, Inc. entered into a Settlement Agreement with Continuation Capital, Inc. covering liabilities with a principal Claim Amount of $1,928,014. Algorhythm agreed to issue Continuation Capital up to 5,000,000 shares of common stock in tranches until Continuation Capital has generated aggregate proceeds equal to 120% of the Claim Amount. A Florida state court approved the Settlement Agreement after a fairness hearing pursuant to Section 3(a)(10) of the Securities Act. The stock issuances are structured as private placements exempt from registration under that section, completed without underwriting discounts, commissions, advertising or general solicitation, and Continuation Capital’s holdings are capped at 19.99% of Algorhythm’s outstanding common stock.

The company also entered into amended and restated employment agreements with CEO Gary Atkinson and CFO and General Counsel Alex Andre. These contracts harmonize their Change of Control treatment by granting, each time such an event occurs, a lump-sum bonus equal to the executive’s Base Salary and Annual Bonus for that year, and include provisions intended to help ensure compliance with Internal Revenue Code Sections 280G, 4999 and 409A.

Positive

  • None.

Negative

  • None.

Filing Explained

The filing identifies the settlement securities as unregistered private-placement transactions under Section 3(a)(10), stating that the offer and sale was and/or will be completed without underwriting discounts or commissions, advertising, or general solicitation.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Claim Amount $1,928,014 Principal amount of liabilities subject to the Settlement Agreement with Continuation Capital, Inc.
Maximum shares issuable to Continuation Capital 5,000,000 shares Ceiling on Algorhythm common stock issuable under the Settlement Agreement
Settlement recovery multiple 120% of the Claim Amount Aggregate proceeds Continuation Capital may generate before share issuance obligation ends
Ownership cap for Continuation Capital 19.99% of outstanding common stock Maximum percentage of Algorhythm common shares Continuation Capital may hold at any time
Settlement Agreement date July 21, 2026 Date Algorhythm and Continuation Capital executed the Settlement Agreement and Stipulation
Fairness hearing approval date July 23, 2026 Date a Florida court approved the Settlement Agreement after a Section 3(a)(10) fairness hearing
Settlement Agreement and Stipulation regulatory
"entered into a settlement agreement and stipulation (the “Settlement Agreement”)"
Section 3(a)(10) regulatory
"fairness hearing pursuant to Section 3(a)(10) of the Securities Act"
A Section 3(a)(10) exemption is a U.S. securities rule that lets a company issue new stock or other securities without registering them with regulators when the terms are reviewed and approved by a court or government official after a hearing. Think of it as a judge signing off on a private trade so it skips the usual public paperwork; for investors, that means quicker deals but potentially less public disclosure and different resale or legal protections compared with registered securities.
fairness hearing regulatory
"entered an order approving the Settlement Agreement after a fairness hearing"
Change of Control financial
"each time, a Change of Control (as defined in the applicable Employment Agreement) occurs"
A change of control occurs when the ownership or management of a company shifts significantly, such as through a sale, merger, or acquisition, resulting in new leadership or ownership structure. This change can impact the company's direction and decision-making, which is important for investors because it may affect the company's stability, strategy, and future prospects.
Section 280G regulatory
"fully comply with Sections 280G, 4999 and 409A of the Internal Revenue Code"
Section 409A regulatory
"fully comply with Sections 280G, 4999 and 409A of the Internal Revenue Code"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What claim is Algorhythm Holdings (RIME) settling with Continuation Capital, Inc.?

Algorhythm is settling liabilities with a principal Claim Amount of $1,928,014 that Continuation Capital, Inc. acquired from former holders. The Settlement Agreement and Stipulation addresses these obligations through issuances of Algorhythm common stock to Continuation Capital in one or more tranches.

How many Algorhythm Holdings (RIME) shares can be issued to Continuation Capital under the settlement?

Algorhythm may issue Continuation Capital up to 5,000,000 shares of common stock. Issuance continues in tranches until Continuation Capital has generated aggregate proceeds equal to 120% of the $1,928,014 Claim Amount as provided in the Settlement Agreement.

What ownership limit applies to Continuation Capital’s Algorhythm Holdings (RIME) common stock?

Continuation Capital’s holdings of Algorhythm common stock are capped at 19.99% of the issued and outstanding shares at any given time. This Beneficial Ownership limitation restricts how many shares Continuation Capital may hold, even as additional tranches are issued under the Settlement Agreement.

How is the Algorhythm Holdings (RIME) stock issuance exempt from SEC registration?

The offer and sale of shares to Continuation Capital are conducted as private placement transactions exempt from registration under Section 3(a)(10) of the Securities Act. A Florida court approved the Settlement Agreement after a fairness hearing, and no underwriting discounts, commissions, advertising or general solicitation are used.

What change-of-control compensation do Algorhythm Holdings (RIME) executives receive under the new agreements?

Under the amended and restated employment agreements, each of the CEO and CFO is entitled, each time a Change of Control occurs during employment, to a lump-sum bonus equal to their Base Salary and Annual Bonus for the year in which the Change of Control occurs.

When were the new Algorhythm Holdings (RIME) executive employment agreements signed and who is covered?

On July 22, 2026, Algorhythm entered into amended and restated employment agreements with CEO Gary Atkinson and CFO and General Counsel Alex Andre. These agreements replace prior contracts and harmonize their change-of-control treatment and tax-related provisions.
false 0000923601 0000923601 2026-07-21 2026-07-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 21, 2026

 

ALGORHYTHM HOLDINGS, INC.

 

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-41405   95-3795478
(State or Other Jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification No.)

 

6301 NW 5th Way, Suite 2900    
Fort Lauderdale, FL   33309
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (954) 800-0425

 

Not Applicable

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01 per share   RIME  

The Nasdaq Stock Market LLC

(The Nasdaq Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On July 21, 2026, Algorhythm Holdings, Inc. (the “Company”) entered into a settlement agreement and stipulation (the “Settlement Agreement”) with Continuation Capital, Inc., a Delaware corporation (“CCI”), with respect to certain outstanding liabilities of the Company in the principal amount of $1,928,014 (the “Claim Amount”) that CCI has acquired from the former holders thereof.

 

Pursuant to the Agreement, the Company agreed to issue CCI up to 5,000,000 shares of the Company’s common stock, par value $0.01 per share (the “Shares”), in one or more tranches until CCI has generated aggregate proceeds equal to 120% of the Claim Amount. On July 23, 2026, the Circuit Court of the Twelfth Judicial Circuit in and for Desoto County, Florida entered an order approving the Settlement Agreement after a fairness hearing pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended (the “Securities Act”). The number of shares of common stock held by CCI at any given time cannot exceed 19.99% of the issued and outstanding shares of the Company’s common stock.

 

The offer and sale of these securities was and/or will be completed by the Company in private placement transactions that are exempt from the registration requirements of the Securities Act pursuant to Section 3(a)(10) of the Securities Act without payment of underwriting discounts or commissions to any person and without engaging in any advertising or general solicitation of any kind.

 

The foregoing is intended to be a summary of the terms of the Agreement and is subject to and qualified in its entirety by the terms of the Agreement, a copy of which is attached hereto as Exhibit 10.3.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The information contained in Item 1.01 above is incorporated by reference herein.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On July 22, 2026, the Company entered into amended and restated employment agreements with: (i) Gary Atkinson, the Company’s Chief Executive Officer, which agreement supersedes and replaces that certain amended and restated employment agreement entered into with Mr. Atkinson on February 23, 2026 (the “CEO Agreement”); and (ii) Alex Andre, the Company’s Chief Financial Officer and General Counsel, which agreement supersedes and replaces that certain employment agreement entered into with Mr. Andre on February 12, 2025 (the “CFO Agreement” and together with the CEO Agreement, the “Employment Agreements”).

 

The Agreements harmonize the change in control treatment applicable to each of the Company’s executive officers. In furtherance thereof, each executive officer now has the right to receive a bonus if, and each time, a Change of Control (as defined in the applicable Employment Agreement) occurs during the term of their employment in a lump sum payment equal to their Base Salary and Annual Bonus (each as defined in the applicable Employment Agreement) for the year in which the Change of Control occurs. The Employment Agreements also include additional provisions designed to ensure that various payments that may in the future be made by the Company to the executive officers fully comply with Sections 280G, 4999 and 409A of the Internal Revenue Code of 1986, as amended.

 

The foregoing is intended to be a summary of the terms of the Employment Agreements and is subject to and qualified in its entirety by the terms of the CEO Agreement and CFO Agreement, a copy of each of which is attached hereto as Exhibits 10.1 and 10.2, respectively.

 

Item 9.01 Financial Statement and Exhibits.

 

Exhibit No.   Description
10.1   Second Amended and Restated Employment Agreement, dated July 22, 2026, by and between Algorhythm Holdings, Inc. and Gary Atkinson
10.2   Amended and Restated Employment Agreement, dated July 22, 2026, by and between Algorhythm Holdings, Inc. and Alex Andre
10.3*   Settlement Agreement and Stipulation, dated July 21, 2026, by and between Algorhythm Holdings, Inc. and Continuation Capital, Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* The schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 24, 2026 ALGORHYTHM HOLDINGS, INC.
     
  By: /s/ Alex Andre
  Name:  Alex Andre
  Title:  Chief Financial Officer and General Counsel

 

 

 

 

Filing Exhibits & Attachments

6 documents